Positive surgical margins after breast-conserving surgery for ductal carcinoma in-situ: does histologic grade or estrogen receptor status matter? Lindsey R. FauveauTuoc N. DaoMichael D. Grant Editorial 07 April 2023 Pages: 215 - 220
Contrast enhanced mammography in breast cancer surveillance Kenneth ElderJulia MathesonGregory Bruce Mann Preclinical study Open access 25 March 2023 Pages: 221 - 230
Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy Hiroji IwataYutaka YamamotoTakuhiro Yamaguchi Clinical trial Open access 22 March 2023 Pages: 231 - 241
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41 Priya RastogiGong TangNorman Wolmark Clinical trial 22 March 2023 Pages: 243 - 252
Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial) Kenichi WatanabeNaoki NiikuraShigehira Saji Clinical trial Open access 31 March 2023 Pages: 253 - 263
Bridging pre-surgical endocrine therapy for breast cancer during the COVID-19 pandemic: outcomes from the B-MaP-C study Rajiv V. DaveBeatrix ElsbergerB-MaP-C study collaborative Clinical trial Open access 03 April 2023 Pages: 265 - 279
Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial Barbara A. ParkerRebecca A. ShatskyThomas J. Kipps Clinical trial Open access 08 April 2023 Pages: 281 - 291
Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologists Carl SarsHelena SackeyEbba K. Lindqvist Epidemiology Open access 06 March 2023 Pages: 293 - 304
Impact of diabetes on surgery and radiotherapy for breast cancer Ross LawrensonChunhuan LaoJason Gurney Epidemiology Open access 30 March 2023 Pages: 305 - 314
Cholesterol and breast cancer risk: a cohort study using health insurance claims and health checkup databases Nobuhiro NariiLing ZhaToshio Ogawa Epidemiology Open access 30 March 2023 Pages: 315 - 322
Hypertensive conditions of pregnancy, preterm birth, and premenopausal breast cancer risk: a premenopausal breast cancer collaborative group analysis Hazel B. NicholsMelissa G. HouseMinouk J. Schoemaker Epidemiology 05 April 2023 Pages: 323 - 334
Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer Christopher GodinaHelga TryggvadottirHelena Jernström Epidemiology Open access 05 April 2023 Pages: 335 - 347
HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series Harriet T. RothschildElle ClellandRita A. Mukhtar Epidemiology Open access 05 April 2023 Pages: 349 - 354
Metaplastic carcinoma of the breast: matched cohort analysis of recurrence and survival Priyanka NarayanCaroline E. KostrzewaLior Z. Braunstein Brief Communication 28 March 2023 Pages: 355 - 361
Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients Francisco AcevedoBenjamín WalbaumCésar Sánchez Brief Communication 29 March 2023 Pages: 363 - 370
Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials Elie RassyThomas FilleronBarbara Pistilli Brief Communication 29 March 2023 Pages: 371 - 379
Aspirin use is associated with improvement in distant metastases outcome in patients with residual disease after neoadjuvant chemotherapy Christopher JohnsSteven K. MontalvoD. W. Nathan Kim Brief Communication 30 March 2023 Pages: 381 - 387
Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisis Joyce M. ChengJenna CanzonieroCesar A. Santa-Maria Brief Communication 31 March 2023 Pages: 389 - 397
Pharmacogenetics: uncovering the complex relationship between HIV and non-adherence among South African breast cancer patients treated with tamoxifen Keneuoe C. NthonthoLeabaneng TaweGiacomo M. Paganotti Letter to the Editor 30 March 2023 Pages: 399 - 400
Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics Shahin SayedHela KokaDhirendra Govender Original Laboratory Investigation 03 April 2023 Pages: 401 - 413